To study whether CDC20 accumulation is involved in the mechanism of drug resistance developed by breast cancer cells, we analyzed CDC20 knockdown or overexpression in two TNBC cell lines, MDA-MB-231 and MDA-MB-468 (Figure 1d,e). The gene discussed is CDC20; the disease is breast carcinoma.